Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Non-thiol-containing peptidomimetic protein farnesyltransferase inhibitors from Merck

July 7, 1999

Verotoxin eliminates astrocytoma tumors in mouse model

July 7, 1999

LG Chemical presents wide series of imidazoles useful as inhibitors of protein farnesyltransferase

July 6, 1999

Search for therapeutically effective protein farnesyltransferase inhibitors continues at Merck

July 6, 1999

Taiho obtains exclusive worldwide rights to potential breast cancer treatment

July 6, 1999

FDA approves initiation of Progen's phase I trial in Australia for PI-88

July 6, 1999

EntreMed extends angiogenesis research agreement with Children's Hospital of Boston

July 6, 1999

Alsterpaullone is a potent CDK1/cyclin B inhibitor and antitumor agent

July 5, 1999

Onyvax and Erasmus University reach prostate cancer agreement

July 5, 1999

The Liposome Company seeks approval for Evacet in the E.U.

July 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...